About Cellerant Therapeutics, Inc

Cellerant Therapeutics is a clinical stage biotechnology company focused on the regulation of the hematopoietic (blood-forming) system. The Company is developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant's lead product, CLT-008 is currently in two Phase 1 clinical trials in patients with – more... 

Claim this company page
Headquarters
San Carlos California, United States
Revenue
$35 Million
Employees
51 to 200
Links
Cellerant Therapeutics, Inc website